|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001675,
umls-concept:C0205265,
umls-concept:C0205470,
umls-concept:C0231174,
umls-concept:C0871261,
umls-concept:C0887947,
umls-concept:C1555582,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C2603343,
umls-concept:C2698872,
umls-concept:C2911692
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2004-6-14
|
|
pubmed:abstractText |
Factors that determine the immunological response to highly active antiretroviral therapy (HAART) are poorly defined.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0022-1899
|
|
pubmed:author |
pubmed-author:DragstedUlrik BakUB,
pubmed-author:EuroSIDA study group,
pubmed-author:HansenAnn-Britt EAB,
pubmed-author:HorbanAndrzejA,
pubmed-author:LundgrenJens DJD,
pubmed-author:MachalaLadislavL,
pubmed-author:MerceyDanielleD,
pubmed-author:MocroftAmandaA,
pubmed-author:PanosGeorgeG,
pubmed-author:VellaStefanoS,
pubmed-author:ViardJean-PaulJP
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
190
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
148-55
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:15195254-Adult,
pubmed-meshheading:15195254-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:15195254-CD4 Lymphocyte Count,
pubmed-meshheading:15195254-Cohort Studies,
pubmed-meshheading:15195254-Europe,
pubmed-meshheading:15195254-Female,
pubmed-meshheading:15195254-HIV Infections,
pubmed-meshheading:15195254-HIV-1,
pubmed-meshheading:15195254-Humans,
pubmed-meshheading:15195254-Male,
pubmed-meshheading:15195254-Middle Aged,
pubmed-meshheading:15195254-Predictive Value of Tests,
pubmed-meshheading:15195254-Prospective Studies,
pubmed-meshheading:15195254-Risk Factors,
pubmed-meshheading:15195254-Substance Abuse, Intravenous,
pubmed-meshheading:15195254-Treatment Outcome,
pubmed-meshheading:15195254-Virus Replication
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA study.
|
|
pubmed:affiliation |
Hvidovre University Hospital, Copenhagen, Denmark. ubd@cphiv.dk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Multicenter Study
|
